Effects of dexmedetomidine infusion in patients undergoing functional endoscopic sinus surgery under local anaesthesia

European Journal of Anaesthesiology

Volumn 25, Issue 1, 2008, Pages 22-28

  Goksu, S ^a   Arik, H ^a   Demiryurek, S ^b   Mumbuc, S ^a   Oner, U ^a   Demiryurek, A T ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Ambulatory surgical procedures; Dexmedetomidine; Nitric oxide; Otorhinolaryngological surgical procedures; Sedation; Surgery

Indexed keywords

ADRENALIN; ALDOLAN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATROPINE; DEXMEDETOMIDINE; NITRIC OXIDE; OZONE; PETHIDINE; PLACEBO; TETRACAINE; UNCLASSIFIED DRUG;

ADULT; ANALGESIA; ARTICLE; BLOOD OXYGEN TENSION; BLOOD PRESSURE; CHEMOLUMINESCENCE; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; ENDOSCOPIC SURGERY; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; LOADING DRUG DOSE; LOCAL ANESTHESIA; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MONITORING; PARANASAL SINUS; PERIOPERATIVE PERIOD; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; PREMEDICATION; SEDATION; SINUSITIS; SPHENOID SINUS; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANALGESIA; ANESTHESIA, LOCAL; BLOOD PRESSURE; CONSCIOUS SEDATION; ELECTROCARDIOGRAPHY; ENDOSCOPY; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NASAL POLYPS; PATIENT SELECTION; SINUSITIS;

EID: 37249063238     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507001317     Document Type: Article

References (25)

1. Slack R, Bates G. Functional endoscopic sinus surgery. Am Fam Phys 1998; 58: 707-718.
2. Danielsen A, Gravningsbraten R, Olofsson J. Anaesthesia in endoscopic sinus surgery. Eur Arch Otorhinolaryngol 2003; 260: 481-486.
3. Lee WC, Kapur TR, Ramsden WN. Local and regional anesthesia for functional endoscopic sinus surgery. Ann Otol Rhinol Laryngol 1997; 106: 767-769.
4. Fedok FG, Ferraro RE, Kingsley CP, Fornadley JA. Operative times, postanesthesia recovery times, and complications during sinonasal surgery using general anesthesia and local anesthesia with sedation. Otolaryngol Head Neck Surg 2000; 122: 560-566.
5. 2-adrenergic agonists. Anesthesiology 2000; 93: 1345-1349.
6. Paris A, Tonner PH. Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol 2005; 18: 412-418.
7. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656-659.
8. Chernik DA, Gillings D, Laine H et al. Validity and reliability of the observer's assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 1990; 10: 244-251.
9. Baylis C, Vallance P. Measurement of nitrite and nitrate levels in plasma and urine - what does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 1998; 7: 59-62.
10. Alasehirli B, Demiryurek S, Arica E, Gursoy S, Demiryurek AT. No evidence for an association between the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and fibromyalgia syndrome. Rheumatol Int 2007; 27: 275-280.
11. Memis D, Turan A, Karamanlioglu B, Pamukcu Z, Kurt I. Adding dexmedetomidine to lidocaine for intravenous regional anesthesia. Anesth Analg 2004; 98: 835-840.
12. Sato J, Perl ER. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 1991; 251: 1608-1610.
13. Esmaoglu A, Mizrak A, Akin A, Turk Y, Boyaci A. Addition of dexmedetomidine to lidocaine for intravenous regional anaesthesia. Eur J Anaesthesiol 2005; 22: 447-451.
14. Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997; 85: 1136-1142.
15. 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther 1989; 46: 33-42.
16. 2- agonist-induced peripheral vasoconstriction in humans. Anesthesiology 2003; 99: 65-70.
17. Piascik MT, Soltis EE, Piascik MM, Macmillan LB. α-Adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates. Pharmacol Ther 1996; 72: 215-241.
18. 2-adrenoceptors in the bradycardic effects of clonidine and analogues. Naunyn Schmiedebergs Arch Pharmacol 1981; 317: 8-12.
19. Vulliemoz Y. The nitric oxide-cyclic 3′,5′-guanosine monophosphate signal transduction pathway in the mechanism of action of general anesthetics. Toxicol Lett 1998; 100-101: 103-108.
20. 2-adrenoceptor-mediated dilations in rat cerebral arteries. Am J Physiol 1995; 269: H1171-H1174.
21. 2-adrenoceptors dilates the rat middle cerebral artery. Anesthesiology 1996; 85: 82-90.
22. 2- adrenergic stimulation in systemic canine arteries and veins. J Pharmacol Exp Ther 1991; 257: 290-293.
23. Ishiyama T, Dohi S, Iida H, Watanabe Y, Shimonaka H. Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg 1995; 81: 1208-1215.
24. 2-adrenergic-mediated cerebral vasoconstriction. Anesth Analg 1994; 78: 67-72.
25. Coughlan MG, Lee JG, Bosnjak ZJ, Schmeling WT, Kampine JP, Warltier DC. Direct coronary and cerebral vascular responses to dexmedetomidine. Significance of endogenous nitric oxide synthesis. Anesthesiology 1992; 77: 998-1006.